Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to Marc Peter Bonaca

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bonaca, Marc

Item TypeName
Concept Platelet Aggregation Inhibitors
Concept Platelet Aggregation
Academic Article Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
Academic Article Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2?P-TIMI 50).
Academic Article Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
Academic Article Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Academic Article Peripheral Revascularization in Patients With?Peripheral Artery Disease With?Vorapaxar: Insights From the TRA 2?P-TIMI 50 Trial.
Academic Article Prasugrel Versus Ticagrelor: Uncertainty Remains.
Academic Article Efficacy and safety of vorapaxar as approved for clinical use in the United States.
Academic Article Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
Academic Article Long-term use of ticagrelor in patients with prior myocardial infarction.
Academic Article Antiplatelet Therapy for Secondary Prevention After Acute Myocardial Infarction.
Academic Article Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
Academic Article Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Academic Article Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2?P-TIMI 50 trial.
Academic Article Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With?Multivessel Coronary Disease.
Academic Article Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.
Academic Article Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
Academic Article SCH 530348: a novel oral thrombin receptor antagonist.
Academic Article Antithrombotics in acute coronary syndromes.
Academic Article Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry.
Academic Article External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
Academic Article Pharmacological treatment and current management of peripheral artery disease.
Academic Article Vorapaxar in the secondary prevention of atherothrombotic events.
Academic Article Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2?P)-TIMI 50.
Academic Article Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Academic Article Antithrombotic Therapy and Major?Adverse Limb Events in Peripheral?Artery?Disease: A Step Forward.
Academic Article Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
Academic Article Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction.
Academic Article Antithrombotic Therapy in Patients With Peripheral Artery Disease.
Academic Article Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Academic Article Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2?P-TIMI 50).
Academic Article Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices.
Academic Article Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Academic Article Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients.
Academic Article Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.
Academic Article Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
Academic Article Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Academic Article Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different.
Academic Article Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Academic Article Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
Academic Article Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2?P-TIMI 50 trial.
Academic Article Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute?Coronary Syndrome.
Academic Article Rivaroxaban in Peripheral Artery Disease after Revascularization.
Academic Article No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials.
Academic Article Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Academic Article Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Academic Article Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
Academic Article Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Academic Article Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Academic Article Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial.
Academic Article Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
Academic Article Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial.
Academic Article Extended dual antiplatelet therapy with ticagrelor 60?mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study.
Academic Article Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Academic Article Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
Academic Article Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes.
Academic Article Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease.
Academic Article Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Academic Article Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Academic Article Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Academic Article Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Academic Article Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.
Academic Article International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care.
Academic Article Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Academic Article Guideline-Directed Medical Therapy in?PAD: Time to Step on the Gas.
Academic Article Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study.
Academic Article Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.

Search Criteria
  • Platelet Aggregation

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)